Atossa Genetics Inc. (NASDAQ:ATOS)
Atossa Genetics Inc. (NASDAQ:ATOS) represented a move of 0 percent or $0.04 per share and closed its previous day trading session at $1.34. 0 Shares were traded in the last trading session with an Average Volume of 485.36 Million Shares. The stock currently has a Market Capitalization of 7.64 Million.
Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company’s diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.
The stock traded between $ 1.12 and $10.68 over 1-Year time period showing its price to sales ratio of 0. Atossa Genetics Inc. (NASDAQ:ATOS) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-5.37 and 200-Day Simple Moving Average of $-57. Its Price to Free Cash Flow is 0 and Price to Book of 0.99.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Atossa Genetics Inc. (NASDAQ:ATOS) reported its Actual EPS of $-0.64/share. The analysts offering Earnings Estimates for the company were believing that Atossa Genetics Inc. could bring EPS of $-0.65/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 1.5 Percent.
iPass Inc. (NASDAQ:IPAS)
In the last trading session, iPass Inc. (NASDAQ:IPAS) added its value by 0% closing at the price of $1.86. The stock currently has market capitalization of 14.32 Million, with average volume of 126.5 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently iPass Inc. (NASDAQ:IPAS) is showing beta of 2.62. This particular value of beta suggests that iPass Inc. (NASDAQ:IPAS) has historically moved 262% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for iPass Inc. (NASDAQ:IPAS) is at $-2.54.
The stock currently has RSI of 49.03. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
iPass Inc provides software-enabled enterprise connectivity services for mobile workers. iPass’ primary service is designed to enable enterprises to provide their employees with secure access to the enterprise’s internal network through an easy-to-use interface.
iPass Inc. (NASDAQ:IPAS) topped its 52-week high price of $6.60 on 12/06/17 and 52-Week Low Price of $1.10 on 11/07/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.82% and monthly volatility of 12.88% respectively.